Sort
10,766 grants matching “checkpoint inhibitor”
Mouse models of Kras-mutant colorectal cancer
$646,021Kevin Michael Haigis · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer
$645,738Emese Zsiros · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Variation in tumor-associated immune profiles and colorectal cancer outcomes
$645,534Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · CA
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation
$645,473Cheryl A London · Tufts University Boston · U01 · FY2022 · CA
Decoding tumor metabolic and immunologic interactions driving racial disparity in African American patients with bladder cancer.
$645,401Nagireddy Putluri · Baylor College Of Medicine · R01 · FY2023 · CA
A phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 08/21/2020
$645,379Elias Sayour · University Of Florida · R01 · FY2025 · FD
PI3K Pathway Mutations in Head and Neck Cancer
$645,333Jennifer R Grandis · University Of California, San Francisco · R01 · FY2020 · DE
Mechanism of acid signaling in bone organ metastases on tumor and myeloid cell evolution towards immune suppression and tumor progression
$645,323Katherine Nelson Weilbaecher · Washington University · R01 · FY2025 · CA
Immunoregulatory role of lung-resident club cell factors in lung cancer
$645,197Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
$644,804Mehmet Toner · Massachusetts General Hospital · R01 · FY2021 · CA
Neoadjuvant immunoradiotherapy for HPV mediated oropharynx cancer
$644,774Joseph A Califano · University Of California, San Diego · R01 · FY2023 · CA
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity
$644,071Iris Z Jaffe · Tufts Medical Center · R01 · FY2019 · CA
Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors
$643,900Terry A Badger · University Of Arizona · R01 · FY2025 · CA
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments
$643,856Calvin J Kuo · Stanford University · R01 · FY2023 · CA
Phase 1 First in Human Trial to Assess Safety and Tolerability of the Novel ACK1 Inhibitor (R)-9b in Patients with Prostate Cancer
$643,764Nupam P Mahajan · Washington University · R01 · FY2025 · CA
Translation of a novel combination therapy approach for non-Hodgkin lymphoma
$643,654Shruthi Naik · Mayo Clinic Rochester · U01 · FY2024 · CA
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments
$643,552Calvin J Kuo · Stanford University · R01 · FY2022 · CA
Precision targeting of T cell cytotoxicity with PET
$643,445Michael John Evans · University Of California, San Francisco · R01 · FY2025 · CA
Chemokine-mediated antigen-specific T cell responses and immunotherapies to treat head and neck cancer
$643,133Dohun Pyeon · Michigan State University · R01 · FY2024 · DE
Exploiting A Critical Vulnerability To Glutamine Antimetabolite Therapy in Fibrolamellar Hepatocellular Carcinoma (FLC)
$643,101Mark Yarchoan · Johns Hopkins University · R01 · FY2025 · CA
Identification of REV-ERB inverse agonists for cancer immunotherapy
$643,014Laura A Solt · Scripps Florida · R01 · FY2020 · CA
HIFU-immunotherapy in pancreatic cancer
$642,831Katherine W Ferrara · Stanford University · R01 · FY2021 · CA
Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer
$642,760Emese Zsiros · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD
$642,579Stefanie Sarantopoulos · Duke University · R01 · FY2019 · HL
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD
$642,579Stefanie Sarantopoulos · Duke University · R01 · FY2018 · HL